Literature DB >> 8418092

Second primary malignancies following gynecological tumours in Saarland, Germany, 1968-1987.

H Brenner1, S Siegle, C Stegmaier, H Ziegler.   

Abstract

The occurrence of second primary malignancies was assessed among 2922 women with cervical cancer, 2721 women with endometrial cancer and 1745 women with malignant neoplasms of the ovaries, who were notified to the cancer registry of Saarland, Germany, between 1968 and 1987. Analyses are presented for second primary malignancies at any site and at the most important single sites. Among women with cervical cancer, 98 second primary malignancies were observed, slightly fewer than the 99.3 cases that would have been expected on the basis of the incidence rates of the general population (standardized incidence ratio, SIR = 0.99). More second malignancies were observed than expected in the urinary bladder (SIR = 3.51) while the opposite applied to second neoplasms in the breast (SIR = 0.56). Among women with endometrial and ovarian cancer, the numbers of observed cases slightly exceeded the expected numbers for second primary neoplasms at any site (SIR = 1.19 and 1.41 respectively). More second primary neoplasms were observed than expected in the colon, breast, urinary bladder and kidneys among these women. We discuss our results, which are in agreement with findings among North European and North American populations, from clinical and etiological points of view.

Entities:  

Mesh:

Year:  1993        PMID: 8418092     DOI: 10.1007/bf01229534

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  15 in total

1.  Second neoplasm--a complication of cancer chemotherapy.

Authors:  B A Chabner
Journal:  N Engl J Med       Date:  1977-07-28       Impact factor: 91.245

2.  Leukemia following chemotherapy for ovarian cancer.

Authors:  J M Kaldor; N E Day; F Pettersson; E A Clarke; D Pedersen; W Mehnert; J Bell; H Høst; P Prior; S Karjalainen
Journal:  N Engl J Med       Date:  1990-01-04       Impact factor: 91.245

Review 3.  Statistical methods in cancer research. Volume II--The design and analysis of cohort studies.

Authors:  N E Breslow; N E Day
Journal:  IARC Sci Publ       Date:  1987

4.  Tissue doses from radiotherapy of cancer of the uterine cervix.

Authors:  M Stovall; S A Smith; M Rosenstein
Journal:  Med Phys       Date:  1989 Sep-Oct       Impact factor: 4.071

5.  Second cancers following radiation treatment for cervical cancer. An international collaboration among cancer registries.

Authors:  J D Boice; N E Day; A Andersen; L A Brinton; R Brown; N W Choi; E A Clarke; M P Coleman; R E Curtis; J T Flannery
Journal:  J Natl Cancer Inst       Date:  1985-05       Impact factor: 13.506

6.  Radiation dose and leukemia risk in patients treated for cancer of the cervix.

Authors:  J D Boice; M Blettner; R A Kleinerman; M Stovall; W C Moloney; G Engholm; D F Austin; A Bosch; D L Cookfair; E T Krementz; H B Latourette; L J Peters; M D Schulz; M Lundell; F Pettersson; H H Storm; C M Bell; M P Coleman; P Fraser; M Palmer; P Prior; N W Choi; T G Hislop; M Koch; D Robb; D Robson; R F Spengler; D von Fournier; R Frischkorn; H Lochmüller; V Pompe-Kirn; A Rimpela; K Kjørstad; M H Pejovic; K Sigurdsson; P Pisani; H Kucera; G B Hutchison
Journal:  J Natl Cancer Inst       Date:  1987-12       Impact factor: 13.506

Review 7.  Multiple primary cancers of the breast, endometrium and ovary.

Authors:  M Ewertz; H H Storm
Journal:  Eur J Cancer Clin Oncol       Date:  1989-12

8.  Cancer following medical irradiation.

Authors:  J D Boice
Journal:  Cancer       Date:  1981-03-01       Impact factor: 6.860

9.  Subsequent primary cancers in relation to treatment of ovarian cancer.

Authors:  P Prior; D J Pope
Journal:  Br J Cancer       Date:  1989-03       Impact factor: 7.640

10.  Methodologic perspectives on the study of multiple primary cancers.

Authors:  W D Thompson
Journal:  Yale J Biol Med       Date:  1986 Sep-Oct
View more
  1 in total

1.  Multiple Primary Malignancies in Patients with Gynecologic Cancer.

Authors:  Eun-Jung Yang; Ji-Hyeon Lee; A-Jin Lee; Nae-Ry Kim; Yong-Taek Ouh; Mi-Kyung Kim; Seung-Hyuk Shim; Sun-Joo Lee; Tae-Jin Kim; Kyeong-A So
Journal:  J Clin Med       Date:  2021-12-26       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.